Detalhe da pesquisa
1.
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial.
BMC Cancer
; 12: 603, 2012 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23244208
2.
Final results of ERASME-4: a randomized trial of first-line docetaxel plus either capecitabine or epirubicin for metastatic breast cancer.
Oncology
; 80(3-4): 262-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21734418
3.
Validation of prognostic scores for survival in cancer patients beyond first-line therapy.
BMC Cancer
; 11: 95, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406082
4.
Outcome of recurrent and metastatic small cell carcinoma of the bladder.
BMC Urol
; 9: 4, 2009 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19500382
5.
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Breast Cancer Res
; 10(5): R88, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18928543
6.
An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trials.
J Clin Epidemiol
; 69: 125-36, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26186899
7.
A methodological framework for drug development in rare diseases.
Orphanet J Rare Dis
; 9: 164, 2014 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25774598
8.
Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome.
Eur J Cancer
; 49(7): 1673-82, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23265706
9.
Experimental designs for small randomised clinical trials: an algorithm for choice.
Orphanet J Rare Dis
; 8: 48, 2013 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23531234
10.
Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.
Radiat Oncol
; 7: 46, 2012 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449081
11.
Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression.
Cancer Res
; 72(20): 5188-97, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22836755
12.
Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study.
Bull Cancer
; 98(9): 80-9, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21926034
13.
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer.
Cancer Res
; 71(16): 5423-34, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697280
14.
Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study.
Clin Nutr
; 29(2): 187-91, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19713014
15.
Factors of interrupting chemotherapy in patients with Advanced Non-Small-Cell Lung Cancer.
BMC Res Notes
; 3: 164, 2010 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20537187
16.
Revisiting the level of evidence in randomized controlled clinical trials: A simulation approach.
Contemp Clin Trials
; 30(5): 400-10, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19576298